Forty cases of mycotic aneurysm that occurred during the period 1993-2007 were reviewed. The most common causative pathogen was Burkholderia pseudomallei (17 cases; 42.5%). Postoperative complications and bacteremia were significantly more common among patients with mycotic aneurysm due to B. pseudomallei than they were among patients with mycotic aneurysm that was not attributable to B. pseudomallei. In a region in which melioidosis is endemic, empirical antimicrobial therapy for suspected mycotic aneurysm should cover B. pseudomallei.
Forty cases of mycotic aneurysm that occurred during the period 1993-2007 were reviewed. The most common causative pathogen was Burkholderia pseudomallei (17 cases; 42.5%). Postoperative complications and bacteremia were significantly more common among patients with mycotic aneurysm due to B. pseudomallei than they were among patients with mycotic aneurysm that was not attributable to B. pseudomallei. In a region in which melioidosis is endemic, empirical antimicrobial therapy for suspected mycotic aneurysm should cover B. pseudomallei.
Mycotic aneurysm is a rare condition that is related to devastating outcomes if diagnosis and treatment are delayed. Even with a combination of surgical and antimicrobial therapy, the mortality rate is 16%-44% [1, 2] . Staphylococcus aureus and Streptococcus species are the most common causative pathogens associated with mycotic aneurysm in Western countries, whereas nontyphoidal Salmonella species and S. aureus are more commonly responsible for cases that occur in Southeast Asian countries [1] [2] [3] [4] . Several case reports of Burkholderia pseudomallei causing infective endarteritis in areas in which melioidosis is endemic have been documented [5, 6] . Whether B. pseudomallei plays an important role as a causative organism of mycotic aneurysm in the region of endemicity is not known. We therefore conducted this study to determine the epidemi-ology of causative pathogens and clinical outcomes of mycotic aneurysm in Northeast Thailand, where melioidosis is endemic.
Patients, materials, and methods. We conducted a retrospective study at Srinagarind University Hospital (Khon Kaen, Thailand), a tertiary-care hospital located in Northeast Thailand. The medical records of patients who received a diagnosis of aortic aneurysm or mycotic aneurysm from 1993 through 2007 were reviewed. Patients were enrolled in the study if they received a diagnosis of mycotic aneurysm, as defined by the presence of the following: (1) bacteremia with radiographic evidence of aneurysm without other documented sources of infection, (2) intraoperative findings suggestive of mycotic aneurysm, such as pus collection around the aneurysm, or (3) pathological evidence of mycotic aneurysm or septic arteritis from the resected aneurysm.
Pathological findings of acute or chronic inflammation, acute suppurative inflammation, abscess formation, and/or bacterial clumps from the excised aneurysm confirmed a diagnosis of infected aneurysm. Appropriate antimicrobial therapy was defined as a prescription of an adequate dosage of a parenteral antibiotic to which the pathogen was fully susceptible, as determined on the basis of the drug susceptibility pattern.
The following patient demographic characteristics were recorded: age, sex, underlying diseases, clinical features, causative organisms, site of vascular involvement, treatment, complications, and outcome. A comparison of these characteristics between patients with mycotic aneurysm caused by B. pseudomallei and patients with mycotic aneurysm caused by other pathogens was performed to evaluate for any clinical difference between groups. Our study protocol was approved by the Institutional Review Board of Khon Kaen University.
Data analyses were performed using SPSS software, version 14 (SPSS). Comparisons between the proportions were performed using Fisher's exact test or Pearson x 2 test, as appropriate. Mean values were compared with use of the Student's t test. Two-tailed tests of significance were used to assess statistical significance at . P ! .05 Results. During the 15-year study period, 928 cases were registered as aortic aneurysm or mycotic aneurysm; of these, 652 (70.3%) had medical records that were available for review. Of these 652 cases, 40 (6.1%) were diagnosed as mycotic aneurysm according to the study criteria. The remaining 612 cases were excluded from the study because of a lack of evidence of intraoperative and pathological findings that were suggestive of mycotic aneurysm.
The majority of the patients were male (32 cases; 80%) and elderly (mean , years). Approximately oneage ‫ע‬ SD 63 ‫ע‬ 11.7 half (23 cases; 57.5%) of the patients had preexisting diseases, of which the 3 most common were diabetes mellitus (9 cases; 22.5%), hypertension (8 cases; 20%), and chronic kidney diseases (7 cases; 17.5%). The remaining preexisting diseases included gout, chronic liver disease, ischemic heart disease, chronic obstructive pulmonary disease, and aplastic anemia. All of the patients presented with localized pain at the site of the aneurysm. A palpable, pulsatile mass (35 cases; 87.5%) and fever (28 cases; 70%) were common clinical features. The median duration of illness was 19 days (range, 3-365 days). The abdominal aorta was involved in 35 cases (87.5%). The minority of cases involved the thoracic aorta, common iliac arteries, and superficial femoral artery.
All but 1 case were culture-proven mycotic aneurysms. The most common etiological pathogens were B. pseudomallei (17 cases; 42.5%) and nontyphoidal Salmonella species (12 cases; 30%). Escherichia coli and Pseudomonas species were found twice each. One case each was due to S. aureus, Aeromonas hydrophila, Klebsiella pneumoniae, Enterobacter species, Enterococcus species, and nonhemolytic, non-group D Streptococcus species. These pathogens were isolated from excised aneurysm (30 cases; 72.5%), blood (9 cases; 22.5%), or pus from the surgical wound (3 cases; 7.5%). The remaining isolates were from samples obtained from intra-abdominal collection, pleural fluid, and pus from another disseminated site of infection.
Thirty-three (84.6%) of the 39 patients with culture-documented cases received appropriate antibiotic therapy. The median period between admission to the hospital and initiation of appropriate antimicrobial therapy was 4 days (range, 0-24 days). All but 1 of the patients with cases due to nontyphoidal Salmonella species received surgical treatment, which was performed within the first few days after hospital admission in 35 cases (89.7%). Postoperative complications occurred in 16 (42.1%) of 38 patients, including acute renal failure (6 patients), surgical wound infection (6 patients, 4 of whom experienced wound evisceration), and severe sepsis and/or septic shock (5 patients). Vascular graft infection occurred in 4 cases, 2 of which were complicated by graft leakage and 1 of which was complicated by aortoduodenal fistula. Acute arterial occlusion was found in 2 patients, whereas gut obstruction and hospital-acquired pneumonia were found in 1 patient each.
The overall in-hospital mortality rate was 20%. The median time from diagnosis to death was 15.5 days (range, 1-42 days). Three patients died of culture-proven disseminated septicemic melioidosis; 1 of these patients had coinfection with extendedspectrum b-lactamase-producing E. coli septicemia. The remaining patient with melioidosis mycotic aneurysm died of massive intra-abdominal bleeding caused by an infected and ruptured vascular graft. Two patients with nontyphoidal Salmonella infection died; one died of massive gastrointestinal bleeding (caused by an infected vascular graft with an aortoduodenal fistula), and the other died of hospital-acquired pneumonia with pneumothorax. One patient with mycotic aneurysm due to K. pneumoniae died during surgery, and 1 patient with mycotic aneurysm due to Enterobacter species died of severe sepsis.
Of the 39 cases of culture-documented mycotic aneurysm, 17 were associated with B. pseudomallei, and 22 were associated with other pathogens. There were no statistically significant differences with respect to age, sex, underlying diseases, clinical presentations, site of aneurysm, positive culture sample site, radiological findings, or mortality between patients with mycotic aneurysm caused by B. pseudomallei and patients with mycotic aneurysm caused by other bacteria ( ) were significantly more common among pa-P p .03 tients with B. pseudomallei mycotic aneurysm than they were among patients with mycotic aneurysm caused by other bacteria.
Discussion. The present study is, to our knowledge, the first to report B. pseudomallei as the pathogen most commonly associated with mycotic aneurysm in regions of melioidosis endemicity. Mycotic aneurysm is a rare presentation of melioidosis, found in 1%-2% of cases and related to high rates of morbidity, mortality, and relapse [7] . This is of particular importance, because our study shows that the clinical features of melioidosis mycotic aneurysm are similar to those of the same condition caused by other bacteria. The presence of underlying comorbid diseases, which is considered to be a significant risk factor for melioidosis, was not helpful in differentiating between the conditions. As with mycotic aneurysm due to nontyphoidal Salmonella species, the major pathogenesis of melioidosis mycotic aneurysm is most likely to be a complication of bacteremia caused by hematogenous seeding in patients with preexisting atherosclerotic diseases.
Overall, in-hospital mortality in our study was high (up to 20% of patients died). This is perhaps attributable to the severity of the disease, because all of our patients were admitted to the hospital with clinical signs that indicated an impending rupture of the aneurysm. There was not a statistically significant difference with respect to mortality rate between patients with melioidosis mycotic aneurysm and those with mycotic aneurysm caused by other bacteria. Patients with melioidosis mycotic aneurysm, however, experienced postoperative complications significantly more often than did patients with mycotic aneurysm caused by other bacteria. The major complications were associated with a failure to control aneurysm-related infection, which resulted in devastating outcomes. The presence of septicemia was significantly greater in melioidosis mycotic aneurysm than in cases caused by other bacteria; in patients with melioidosis mycotic aneurysm who died, the cause of death was directly related to disseminated septicemic melioidosis. The natural course of fulminating septicemic melioidosis and delay of appropriate antimicrobial therapy might explain the fatal outcome in these patients. A prolonged course of antibiotic therapy plus surgical intervention is considered to be the most appropriate management of this condition; however, this is also a source of concern, because B. pseudomallei is resistant to many antimicrobial agents that are commonly used for empirical treatment of community-acquired infection. Notwithstanding persistent high mortality, ceftazidime is the drug of choice for the treatment of severe melioidosis, because it reduces mortality by one-half, compared with treatment with conventional drugs [8, 9] . Therefore, we suggest that patients who live in areas where melioidosis is endemic and who have clinical suspicion of mycotic aneurysm should receive empirical antibiotics that cover B. pseudomallei. In the event that melioidosis mycotic aneurysm is detected, a combination of trimethoprim-sulfamethoxazole and doxycycline for 12-20 weeks must be given after prolonged appropriate parenteral antibiotic therapy (usually 6-8 weeks) for prevention of relapse [10, 11] .
The major limitations of our study were the retrospective study design and the fact that only 70% of medical records were available for review, which resulted in a selection bias. The evaluation of causative organisms was based on an aerobic culture, so we could not explore the role of anerobic bacteria or other uncommon organisms in this condition. Differences in the management of the cases might also have biased the treatment outcomes. Late complications are not known, because there was a lack of long-term follow-up information.
The present study, to our knowledge, is the largest series of cases of B. pseudomallei mycotic aneurysm to date. It emphasizes the importance of this pathogen as the most common causative agent of mycotic aneurysm in a region where melioidosis is endemic.
